Auro Laboratories Ltd

About

Auro Laboratories is dealing in the business of Active Pharmaceutical Ingredients (APIs). The company specializes in producing Anti Diabetics APIs.

Key API Products of Auro Labs are: [1]
- Metformin Hydrochloride
- Chlorzoxzone
- Chlorphenamine Maleate

Key Points

Expansion Details [1]
The company is undertaking expansion plan in existing unit to increase production capacity. Total cost of the project is 12.5 Cr.

See full details
  • Market Cap 85.3 Cr.
  • Current Price 137
  • High / Low 195 / 67.0
  • Stock P/E 12.4
  • Book Value 45.9
  • Dividend Yield 0.00 %
  • ROCE 38.9 %
  • ROE 28.7 %
  • Face Value 10.0

Pros

  • Company is almost debt free.
  • Company has delivered good profit growth of 52.17% CAGR over last 5 years
  • Company has a good return on equity (ROE) track record: 3 Years ROE 26.19%

Cons

  • Though the company is reporting repeated profits, it is not paying out dividend
Loading peers table ...

Quarterly Results

Figures in Rs. Crores

Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021
12.55 12.28 11.53 13.72 11.10 9.54 9.43 12.22 15.35 13.11 13.56 10.53
11.30 10.04 9.45 12.05 8.92 7.96 8.60 10.04 12.19 10.25 10.51 9.16
Operating Profit 1.25 2.24 2.08 1.67 2.18 1.58 0.83 2.18 3.16 2.86 3.05 1.37
OPM % 9.96% 18.24% 18.04% 12.17% 19.64% 16.56% 8.80% 17.84% 20.59% 21.82% 22.49% 13.01%
Other Income 0.26 0.07 0.59 0.26 0.22 0.11 0.38 0.06 0.28 0.25 0.17 0.50
Interest 0.19 0.18 0.13 0.16 0.11 0.10 0.21 0.08 0.08 0.05 0.25 0.11
Depreciation 0.26 0.28 0.22 0.25 0.26 0.28 0.23 0.25 0.25 0.26 0.28 0.26
Profit before tax 1.06 1.85 2.32 1.52 2.03 1.31 0.77 1.91 3.11 2.80 2.69 1.50
Tax % 25.47% 24.86% 31.47% 27.63% 29.06% 21.37% 38.96% 27.75% 27.65% 27.50% 43.49% 29.33%
Net Profit 0.80 1.38 1.58 1.10 1.45 1.04 0.46 1.39 2.25 2.03 1.52 1.07
EPS in Rs 1.28 2.21 2.54 1.76 2.33 1.67 0.74 2.23 3.61 3.26 2.44 1.72

Profit & Loss

Figures in Rs. Crores

Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021 TTM
12.08 20.83 25.44 44.28 33.74 32.65 27.91 35.47 40.79 46.82 43.79 54.25 52.55
11.32 19.09 23.33 41.01 30.95 29.71 25.11 31.03 34.43 39.83 37.51 43.01 42.11
Operating Profit 0.76 1.74 2.11 3.27 2.79 2.94 2.80 4.44 6.36 6.99 6.28 11.24 10.44
OPM % 6.29% 8.35% 8.29% 7.38% 8.27% 9.00% 10.03% 12.52% 15.59% 14.93% 14.34% 20.72% 19.87%
Other Income 0.08 0.03 0.05 0.06 0.06 0.24 0.42 0.53 0.51 0.96 0.97 0.76 1.20
Interest 0.42 1.12 1.43 1.85 1.53 1.66 1.66 1.18 1.21 0.87 0.58 0.46 0.49
Depreciation 0.34 0.44 0.47 0.72 0.74 0.72 0.68 0.86 0.93 1.01 1.02 1.04 1.05
Profit before tax 0.08 0.21 0.26 0.76 0.58 0.80 0.88 2.93 4.73 6.07 5.65 10.50 10.10
Tax % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 72.01% 25.16% 27.51% 27.96% 31.62%
Net Profit 0.08 0.21 0.26 0.77 0.58 0.80 0.88 0.82 3.53 4.40 4.05 7.18 6.87
EPS in Rs 0.13 0.34 0.42 1.24 0.93 1.28 1.41 1.32 5.66 7.06 6.50 11.52 11.03
Dividend Payout % 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Compounded Sales Growth
10 Years:10%
5 Years:14%
3 Years:10%
TTM:24%
Compounded Profit Growth
10 Years:43%
5 Years:52%
3 Years:27%
TTM:58%
Stock Price CAGR
10 Years:36%
5 Years:27%
3 Years:26%
1 Year:77%
Return on Equity
10 Years:21%
5 Years:25%
3 Years:26%
Last Year:29%

Balance Sheet

Figures in Rs. Crores

Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
6.23 6.23 6.23 6.23 6.23 6.23 6.23 6.23 6.23 6.23 6.23 6.23
Reserves -1.14 -0.94 -0.68 0.09 0.67 1.47 2.35 3.18 6.75 11.18 15.27 22.35
Borrowings 10.86 12.90 15.94 16.75 14.80 16.41 12.62 4.95 9.20 8.09 3.16 3.16
2.48 4.09 5.22 6.75 5.14 4.67 4.49 12.45 8.23 7.97 7.68 10.15
Total Liabilities 18.43 22.28 26.71 29.82 26.84 28.78 25.69 26.81 30.41 33.47 32.34 41.89
5.25 6.85 6.38 10.68 10.51 9.80 9.13 13.00 13.02 14.59 14.24 13.56
CWIP 1.87 0.65 4.43 0.00 0.06 0.82 3.33 0.23 1.07 0.12 0.12 0.13
Investments 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05 0.05
11.26 14.73 15.85 19.09 16.22 18.11 13.18 13.53 16.27 18.71 17.93 28.15
Total Assets 18.43 22.28 26.71 29.82 26.84 28.78 25.69 26.81 30.41 33.47 32.34 41.89

Cash Flows

Figures in Rs. Crores

Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
-0.01 -0.47 2.50 1.46 4.48 -0.78 7.88 6.49 6.05 6.87 9.30 12.82
-1.85 -0.82 -3.75 -0.52 -0.56 -0.73 -2.44 -2.20 -3.04 -3.19 -2.21 -3.51
2.48 1.17 1.01 -0.79 -2.99 0.53 -5.34 -3.81 -1.77 -1.83 -5.52 -0.46
Net Cash Flow 0.62 -0.12 -0.24 0.15 0.93 -0.98 0.09 0.47 1.24 1.86 1.58 8.85

Ratios

Figures in Rs. Crores

Mar 2010 Mar 2011 Mar 2012 Mar 2013 Mar 2014 Mar 2015 Mar 2016 Mar 2017 Mar 2018 Mar 2019 Mar 2020 Mar 2021
Debtor Days 80.07 78.85 42.47 66.52 46.95 94.80 66.04 79.13 74.90 66.26 48.18 49.12
Inventory Days 265.25 164.31 174.50 72.37 115.33 89.37 86.72 21.65 22.00 42.98 60.54 32.60
Days Payable 93.93 75.35 89.54 0.00 0.00 0.00 0.00 80.26 78.26 66.19 70.67 73.51
Cash Conversion Cycle 251.39 167.81 127.43 138.89 162.28 184.17 152.77 20.52 18.64 43.05 38.04 8.20
Working Capital Days 243.84 173.13 144.48 95.45 99.20 138.51 97.30 67.20 64.61 63.46 51.18 34.58
ROCE % 3.45% 7.73% 8.52% 11.71% 9.43% 10.74% 11.21% 23.06% 32.51% 29.11% 24.84% 38.87%

Shareholding Pattern

Numbers in percentages

Sep 2018 Dec 2018 Mar 2019 Jun 2019 Sep 2019 Dec 2019 Mar 2020 Jun 2020 Sep 2020 Dec 2020 Mar 2021 Jun 2021
51.61 51.74 51.89 51.92 51.92 51.92 51.92 51.92 51.92 51.92 51.92 51.92
0.01 0.01 0.01 0.01 0.01 0.04 0.01 0.01 0.01 0.01 0.01 0.01
48.38 48.25 48.10 48.07 48.07 48.04 48.07 48.07 48.07 48.07 48.07 48.07

Documents